Zobrazeno 1 - 10
of 10
pro vyhledávání: '"I. A. Sadulaeva"'
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 14-18 (2018)
Aim. To assess the influence of retinol-binding protein synthetized by adipose tissue, on clinical course and prognosis of arterial hypertension (AH).Material and methods. Totally, 168 patients included, with AH of 1-3 grade. Study protocol included
Externí odkaz:
https://doaj.org/article/6ff145fcd96743acab7d8d1b6bbde6a6
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 4, Iss 3, Pp 76-82 (2016)
Aim. To assess influence of combined antihypertensive (captopril or metoprolol) and antidepressant (thianeptin or sertralin) therapy on clinical status, blood pressure (BP) and myocardial function in patients with arterial hypertension (HT) and affec
Externí odkaz:
https://doaj.org/article/1c120837c6524204b82ba05ad53b8f30
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 3, Iss 1, Pp 41-47 (2015)
So-called “metabolic” direction has been developing intensively during last decades. Its aim is the theoretical and practical analysis of the role of metabolic disorders in initiation and progression of many diseases. The pathogenic peculiarities
Externí odkaz:
https://doaj.org/article/17c966f960154848b5e19352066b90fe
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 12, Pp 56-62 (2015)
Aim. Assessment of structural and functional condition of the left and right heart chambers related to the level of NT-proBNP and clinical signs of CHD in AH patients.Material and methods. Totally, 137 AH patients studied (45 men, 92 women) with sinu
Externí odkaz:
https://doaj.org/article/7debc6e7fc4a479aac99af781a14e42e
Autor:
E. Yu. Shupenina, E. N. Yushchuk, A. B. Khadzegova, S. V. Ivanova, I. A. Sadulaeva, E. V. Nadina, A. M. Khuchinaeva, Yu. A. Vasyuk
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 12, Iss 3, Pp 85-88 (2013)
Cardiovascular disease (CVD) remains the leading cause of death in most developed countries. Morphological and functional status of large arteries plays an important role in the pathogenesis of CVD. At the moment, there are two main methods of aortic
Externí odkaz:
https://doaj.org/article/3f3461185166402da74d854ee0235754
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 3, Iss 1, Pp 41-47 (2015)
So-called “metabolic” direction has been developing intensively during last decades. Its aim is the theoretical and practical analysis of the role of metabolic disorders in initiation and progression of many diseases. The pathogenic peculiarities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19160133d27e3ea9717ef328570a6a88
http://www.rpcardio.ru/jour/article/view/384
http://www.rpcardio.ru/jour/article/view/384
Autor:
Iu A, Vasiuk, I A, Sadulaeva, E N, Iushchuk, O S, Trofimenko, M V, Chirkov, V S, Fedoseeva, K G, Kulikov
Publikováno v:
Terapevticheskii arkhiv. 82(9)
The paper covers current problems in the treatment of arterial hypertension. Renin is an important and promising therapeutic target. The direct renin inhibitor aliskiren (Rasilez) is a promising current effective antihypertensive agent that has cardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8c32c7a010519aa391c8c8e937d479a7
https://pubmed.ncbi.nlm.nih.gov/21086622
https://pubmed.ncbi.nlm.nih.gov/21086622
Publikováno v:
Kardiologiia. 44(8)
According to results of multiple studies depression and anxiety are found in more than 50% of patients with hypertension. Presence of affective disorders elevates risk of progression of hypertension. That is why complex therapy comprising antihyperte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0b674a71359870907b30fcac5ce71773
https://pubmed.ncbi.nlm.nih.gov/15340337
https://pubmed.ncbi.nlm.nih.gov/15340337
Autor:
Iu A, Vasiuk, E N, Iushchuk, E L, Shkol'nik, A B, Khadzegova, I A, Sadulaeva, N K, Vit'ko, M N, Vakhromeeva
Publikováno v:
Europe PubMed Central
To study efficacy of the myocardial cytoprotector trimethasidine MB and metabolic drug 3-(2,2,2-trimethylhydrasine) propionate dihydrate (3-TMHP) in the treatment of chronic cardiac failure (CCF).Sixty-five patients with CCF after myocardial infarcti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::45a51fc3ffb1d73a19d8dad09d4f4be0
http://europepmc.org/abstract/med/17460970
http://europepmc.org/abstract/med/17460970
Autor:
I A Sadulaeva, Yu A Vasyuk, O S Trofimenko, E N Yushchuk, S V Ivanova, E Yu Shupenina, E A Nesterova
Publikováno v:
Терапевтический архив, Vol 88, Iss 10, Pp 93-98 (2016)
The presence of metabolic syndrome (MS) in a patient allows him to be assigned to a group at high risk for atherosclerosis, cardiovascular events, coronary heart disease, and type 2 diabetes mellitus. In addition, MS negatively affects not only the h
Externí odkaz:
https://doaj.org/article/10cd3ec0af4c4a189bda963e59a7ab9c